Principal Financial Group’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.1K Sell
12,160
-1,829
-13% -$4.23K ﹤0.01% 2205
2025
Q1
$19.4K Sell
13,989
-982
-7% -$1.37K ﹤0.01% 2148
2024
Q4
$25.9K Sell
14,971
-828
-5% -$1.43K ﹤0.01% 2192
2024
Q3
$31.8K Sell
15,799
-5,810
-27% -$11.7K ﹤0.01% 2196
2024
Q2
$48.4K Buy
+21,609
New +$48.4K ﹤0.01% 2287